Riverhead Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$365K Sell
2,700
-400
-13% -$52.4K 0.01% 859
2019
Q2
$378K Sell
3,100
-300
-9% -$33.2K 0.01% 856
2019
Q1
$354K Buy
3,400
+400
+13% +$41.3K 0.01% 867
2018
Q4
$342K Sell
3,000
-678
-18% -$72.6K 0.02% 821
2018
Q3
$424K Sell
3,678
-50
-1% -$5.48K 0.02% 825
2018
Q2
$386K Buy
3,728
+64
+2% +$6.48K 0.02% 779
2018
Q1
$361K Sell
3,664
-368
-9% -$34.8K 0.02% 794
2017
Q4
$342K Buy
4,032
+82
+2% +$6.77K 0.01% 832
2017
Q3
$304K Sell
3,950
-5,306
-57% -$406K 0.01% 799
2017
Q2
$721K Buy
9,256
+2,956
+47% +$211K 0.04% 473
2017
Q1
$453K Sell
6,300
-2,000
-24% -$138K 0.02% 562
2016
Q4
$515K Sell
8,300
-360
-4% -$22K 0.03% 489
2016
Q3
$561K Buy
8,660
+4,106
+90% +$273K 0.04% 437
2016
Q2
$56K Sell
4,554
-22,204
-83% -$1.31M ﹤0.01% 1302
2016
Q1
$1.55M Sell
26,758
-1,042
-4% -$59K 0.02% 584
2015
Q4
$1.49M Buy
27,800
+20,700
+292% +$1.17M 0.02% 587
2015
Q3
$362K Buy
+7,100
New +$382K 0.01% 597

Other funds holding RMD

Riverhead Capital Management's RMD Position: Q3 2019 in Review

Riverhead Capital Management reduced its ResMed (RMD) stake by 13% in Q3 2019, selling an estimated $52.4K and leaving 2,700 shares worth $365K. The position accounts for 0.01% of the portfolio, ranked #859.

Riverhead Capital Management first reported a position in RMD in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.55M in Q1 2016. 528 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

  • Riverhead Capital Management held 2,700 shares of ResMed worth $365K as of Q3 2019.
  • Riverhead Capital Management sold 400 ResMed shares in Q3 2019, an estimated $52.4K.
  • ResMed made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #859 holding.
  • Riverhead Capital Management first reported a position in ResMed in Q3 2015 and has held it in 17 quarters since.
  • Riverhead Capital Management's ResMed position peaked at $1.55M in Q1 2016.
  • 528 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.